| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeffc9566b97dd7eb67af69a93215fe3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e6859cf301a65d87dbfec3c92995f2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97783cd02e31b05269f3e999bdda3fa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_403d0142f88cc2dc61c3fb33c4645db3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2698edeea628c37dee810a47223cbcf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 |
| filingDate |
2008-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98fbb9b770978e023730d329878a2ef3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c7aa18daa105edda6e26b7964e5842b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1580f5a7e1342f4dfc1407e1a6e6523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_230a7b69cb007649d9b4a00751ad60b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c383bf3ceadeaeff15c01af2ae7fed1 |
| publicationDate |
2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015017265-A9 |
| titleOfInvention |
Methods of modifying myocardial infarction expansion |
| abstract |
A bioscaffolding can be formed within a post-myocardial infarct region sufficient to cause attenuation of a rate of myocardial infarct expansion. A bioscaffolding may further be formed in the post-myocardial infarct region to cause an increase in posterior left ventricular wall thickness. The gel or bioscaffolding can be formed from a mixture of gel components of different gelation systems. For example, a bioscaffolding can be formed by mixing at least two different components of at least two different two-component gelation systems to form a first mixture and by mixing at least two different components (other than the components that make up the first mixture) of the at least two different two-component gelation systems to form a second mixture. |
| priorityDate |
2006-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |